<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">Although SARS-CoV and SARS-CoV-2 are similar in many respects, they present genetic and structural differences.
 <xref rid="bib0760" ref-type="bibr">
  <sup>64</sup>
 </xref> The novel virus is characterised by the ease with which it spreads
 <xref rid="bib0765" ref-type="bibr">
  <sup>65</sup>
 </xref>; it is more contagious than SARS-CoV,
 <xref rid="bib0770" ref-type="bibr">
  <sup>66</sup>
 </xref> spreading through respiratory droplets and contact with infected individuals and objects. It can also be spread by asymptomatic infected individuals.
 <xref rid="bib0775" ref-type="bibr">67</xref>, 
 <xref rid="bib0780" ref-type="bibr">68</xref>, 
 <xref rid="bib0785" ref-type="bibr">69</xref> Several observational studies have analysed the symptoms of the disease, but few have addressed neurological symptoms, with the exception of headache and vestibular symptoms in observational studies
 <xref rid="bib0790" ref-type="bibr">70</xref>, 
 <xref rid="bib0795" ref-type="bibr">71</xref>, 
 <xref rid="bib0800" ref-type="bibr">72</xref>, 
 <xref rid="bib0805" ref-type="bibr">73</xref>, 
 <xref rid="bib0810" ref-type="bibr">74</xref>, 
 <xref rid="bib0815" ref-type="bibr">75</xref> and a specific study of these symptoms in hospitalised patients,
 <xref rid="bib0820" ref-type="bibr">
  <sup>76</sup>
 </xref> and isolated case reports
 <xref rid="bib0825" ref-type="bibr">
  <sup>77</sup>
 </xref>. However, it has been suggested that the virus may affect the CNS, similarly to SARS-CoV, which was detected in the brains of some patients.
 <xref rid="bib0830" ref-type="bibr">
  <sup>78</sup>
 </xref> Clinical data reveal differential characteristics, including olfactory alterations and hallucinations; these symptoms have not been reported in patients with SARS-CoV or MERS-CoV infection. Several features of SARS-CoV-2 support the hypothesis of a particular affinity for the CNS.
</p>
